AGX (NYSE: AGX) resale notice: insider sales and a 2,581-share exercise
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
AGX filed a Form 144 reporting proposed resale following an exercise of options under a registered plan on 04/01/2026 for 2,581 shares of Common Stock to be sold by the issuer for cash. The filing also lists two sales by Peter W. Getsinger on 01/07/2026 (4,000 shares, $1,313,353.88) and 01/08/2026 (6,595 shares, $2,068,918.11).
Positive
- None.
Negative
- None.
Key Figures
Resale after exercise: 2,581 shares
Sale by Peter W. Getsinger: 4,000 shares
Sale by Peter W. Getsinger: 6,595 shares
3 metrics
Resale after exercise
2,581 shares
exercise under a registered plan on 04/01/2026
Sale by Peter W. Getsinger
4,000 shares
sold on 01/07/2026 for $1,313,353.88
Sale by Peter W. Getsinger
6,595 shares
sold on 01/08/2026 for $2,068,918.11
Key Terms
Exercise of options under a registered plan, Form 144, Issuer
3 terms
Exercise of options under a registered plan regulatory
"Exercise of options under a registered plan on 04/01/2026"
Form 144 regulatory
"Filer Information | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Issuer financial
"Issuer | 2581 | 04/01/2026 | Cash"
FAQ
What does AGX's Form 144 report about recent transactions?
It reports a proposed resale of 2,581 shares after option exercise. The filing records an exercise under a registered plan on 04/01/2026 and shows prior cash sales by Peter W. Getsinger on 01/07/2026 and 01/08/2026 for specified share counts and dollar values.
Does the AGX excerpt state who will receive proceeds from the 04/01/2026 sale?
The excerpt indicates the issuer is the reporting seller for the 04/01/2026 transaction. It identifies the method as cash and the action as an exercise of options under a registered plan; further use-of-proceeds detail is not provided in the excerpt.